Homefinancing

financing

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

VuNet raises $7m to boost global expansion and product innovation

Jim Cornall - January 29, 2025

financing

Report says UK needs more venture capital expertise in deeptech to boost domestic investment

Jim Cornall - January 28, 2025

biotech

SXSW announces 2025 pitch competition finalists

Jim Cornall - January 21, 2025

financing

Iceland to Showcase tech startup scene at Slush 2024

Jim Cornall - November 19, 2024

financing

EIC investing €1.4bn in deeptech in 2025

Jim Cornall - November 12, 2024

financing

Funding for Singapore deeptech spinoffs

Jim Cornall - November 11, 2024

financing

GITEX Editions debuts to redefine global power tech domination

Jim Cornall - October 25, 2024

financing

Event connects 500 investors with deeptech startups

Jim Cornall - October 8, 2024

123 Page 2 of 3

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0